KEENAN GREG (SVP, Chief Medical Officer) reported 1 transaction at AURINIA PHARMACEUTICALS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/3/2026ACC: 0002044006-26-000002
Officer· SVP, Chief Medical Officer
Since Feb 2026
-11.55K
Net shares
Net seller
$167.9K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
11.55K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−11.55K
Price / share
$14.53
Trade value
$167.85K
% of position
8.7%
2/2/2026
133.48K→121.93K
Total
Net shares
−11.55K
Net value
-$167.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | F · Tax Withholding | −11.55K | $14.53 | $167.85K | 8.7% | 133.48K | 121.93K |
| Total | −11.55K | -$167.85K | ||||||
Derivative Transactions0
No derivative transactions reported